Results 31 to 40 of about 943,135 (348)

NLLSS: Predicting Synergistic Drug Combinations Based on Semi-supervised Learning. [PDF]

open access: yesPLoS Computational Biology, 2016
Fungal infection has become one of the leading causes of hospital-acquired infections with high mortality rates. Furthermore, drug resistance is common for fungus-causing diseases.
Xing Chen   +5 more
doaj   +1 more source

Oncology drug-companion diagnostic combinations

open access: yesCancer Treatment and Research Communications, 2021
With the development of trastuzumab for metastatic breast cancer a new era began in cancer drug development. The drug-diagnostic codevelopment model with its clinical enrichment trial design has enabled development of target specific drugs for molecular ...
Jan Trøst Jørgensen
doaj  

Drug Combinations: Mathematical Modeling and Networking Methods

open access: yesPharmaceutics, 2019
Treatments consisting of mixtures of pharmacological agents have been shown to have superior effects to treatments involving single compounds. Given the vast amount of possible combinations involving multiple drugs and the restrictions in time and ...
Vahideh Vakil, Wade Trappe
doaj   +1 more source

Systematic Prediction of Antifungal Drug Synergy by Chemogenomic Screening in Saccharomyces cerevisiae

open access: yesFrontiers in Fungal Biology, 2021
Since the earliest days of using natural remedies, combining therapies for disease treatment has been standard practice. Combination treatments exhibit synergistic effects, broadly defined as a greater-than-additive effect of two or more therapeutic ...
Hamid Gaikani   +6 more
doaj   +1 more source

Impact of additional selexipag on prostacyclin infusion analogs in patients with pulmonary arterial hypertension

open access: yesRespiratory Medicine Case Reports, 2022
The effective therapy for pulmonary arterial hypertension (PAH) with inadequate clinical response is scarce except for lung transplantation when prostacyclin infusion is ineffective.
Mizuki Momoi   +7 more
doaj  

Inhibitory Mechanisms of DHA/CQ on pH and Iron Homeostasis of Erythrocytic Stage Growth of Plasmodium falciparum

open access: yesMolecules, 2019
Malaria is an infectious disease caused by Plasmodium group. The mechanisms of antimalarial drugs DHA/CQ are still unclear today. The inhibitory effects (IC50) of single treatments with DHA/CQ or V-ATPase inhibitor Baf-A1 or combination treatments by DHA/
Tian Tang   +6 more
doaj   +1 more source

Long-term drug use and polypharmacy among the elderly population in the Republic of Srpska, Bosnia and Herzegovina [PDF]

open access: yesVojnosanitetski Pregled, 2016
Background/Aim. Prescription of drugs is a fundamental care component of the elderly. Elderly patients often take multiple drugs, and it is known that polypharmacy may lead to drug interactions and adverse events.
Marković-Peković Vanda, Škrbić Ranko
doaj   +1 more source

A Bayesian seamless phase I-II trial design with two stages for cancer clinical trials with drug combinations

open access: yes, 2020
The use of drug combinations in clinical trials is increasingly common during the last years since a more favorable therapeutic response may be obtained by combining drugs.
Jiménez, José L.   +2 more
core   +1 more source

LIM kinase inhibitors disrupt mitotic microtubule organization and impair tumor cell proliferation [PDF]

open access: yes, 2015
The actin and microtubule cytoskeletons are critically important for cancer cell proliferation, and drugs that target microtubules are widely-used cancer therapies. However, their utility is compromised by toxicities due to dose and exposure. To overcome
Baugh, Mark   +18 more
core   +2 more sources

Drug Interactions in Lenacapavir-Based Long-Acting Antiviral Combinations

open access: yesViruses, 2022
Long-acting (LA) anti-HIV regimens show promise for increasing dosing intervals and consequently, improving the patients’ quality of life. The first FDA-approved LA therapy is Cabenuva, which comprises rilpivirine (a non-nucleoside reverse transcriptase ...
Maria E. Cilento   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy